Fujiwara Takashi, Ohira Kasumi, Urushibara Ko, Ito Akihiro, Yoshida Minoru, Kanai Misae, Tanatani Aya, Kagechika Hiroyuki, Hirano Tomoya
Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan.
Department of Chemistry, Faculty of Science, Ochanomizu University, 2-1-1 Otsuka, Bunkyo-ku, Tokyo 112-8610, Japan.
Bioorg Med Chem. 2016 Sep 15;24(18):4318-4323. doi: 10.1016/j.bmc.2016.07.024. Epub 2016 Jul 12.
Set7/9 is a histone lysine methyltransferase, but it is also thought to be involved in a wide variety of pathophysiological functions. We previously identified cyproheptadine, which has a characteristic butterfly-like molecular conformation with bent tricyclic dibenzosuberene and chair-form N-methylpiperidine moieties, as a Set7/9 inhibitor. In this work, we synthesized several derivatives in order to examine the steric structure-inhibitory activity relationship. We found that even a small change of molecular shape due to reduction or replacement of the 10,11-olefinic bond of the tricyclic ring generally resulted in a drastic decrease of the inhibitory activity. Our results should be useful not only for development of more potent and selective inhibitors, but also for the construction of novel inhibitor scaffolds.
Set7/9是一种组蛋白赖氨酸甲基转移酶,但人们也认为它参与多种病理生理功能。我们之前鉴定出赛庚啶是一种Set7/9抑制剂,它具有独特的蝴蝶状分子构象,带有弯曲的三环二苯并环庚烯和椅式N-甲基哌啶部分。在这项研究中,我们合成了几种衍生物,以研究空间结构与抑制活性的关系。我们发现,即使由于三环10,11-烯烃键的还原或取代导致分子形状发生微小变化,通常也会导致抑制活性急剧下降。我们的研究结果不仅有助于开发更有效、更具选择性的抑制剂,也有助于构建新型抑制剂支架。